2015 saw a lot of action in the Myeloma world. Four new drugs were approved by the FDA increasing treatment options and allowing new combination regimens; promising immunotherapy research results will see these being used in clinical practice and 1000 myeloma patients have been enrolled for the MMRF's CoMMpass study. We are talking to Anne Quinn Young of the MMRF to understand the significance of progress in myeloma research in 2015 for the myeloma patient community as well as review MMRF research initiatives in the last year and what patients can expect in the coming new year.
Sorry we couldn't complete your registration. Please try again.
You must accept the Terms and conditions to register